News and Media
Press Release - Jan 23, 2025
We are excited to share the encouraging preliminary results from the Phase 1b/2a iLSTA trial, which evaluates certepetide in combination with standard chemotherapy and immunotherapy for treating locally advanced non-resectable pancreatic ductal adenocarcinoma (PDAC). This trial, conducted by WARPNINE in collaboration with Lisata Therapeutics, shows promising outcomes that could transform treatment for pancreatic cancer patients.
The results, presented at the 2025 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, highlight significant tumour response and immune system activation, paving the way for potential new treatment options.
Read the full press release for more details on this groundbreaking research.
7NEWS Perth Covers WARPNINE’s
24-Hour Boxing Challeng
We are incredibly proud to have WARPNINE’s 24-Hour Boxing Challenge featured on 7NEWS Perth, highlighting the power of our community in the fight against pancreatic, gastrointestinal, and rare cancers.
This challenge isn’t just about endurance—it’s about pushing the boundaries to accelerate access to life-changing clinical trials. Thank you to everyone who has supported this initiative, from participants to donors and advocates.
​
📺 Watch the full feature below to see the impact of your support in action.
6PR's Karalee Katsambanis speaks with WARPNINE CEO,
Meg Croucher.
Dive into an empowering conversation that will fuel your spirit! Karalee Katsambanis from 6PR delves deep into Meg Croucher's inspiring journey ahead of her 24-hour boxing bag-work challenge for WARPNINE.
​
Meg's unwavering dedication and determination are nothing short of incredible. Discover her heartfelt reasons and be part of this impactful initiative. Let's unite, share the inspiration, and create change together!
​​
Catch the full radio interview from Saturday afternoon:
7 News Exclusive
Watch our Exclusive on 7 News Perth
​
The homegrown treatment giving new hope to cancer patients.
​
WA doctors have become the first in the world to trial what could be one of the biggest cancer breakthroughs.
​
​
PerthNow Exclusive
Read our Exclusive in PerthNow 7 News Perth
​
Perth charity Warpnine’s crazy approach to fundraising... and it just might work
​
Xander Sapsworth-CollisPerthNow - Western Suburbs
April 14, 2023 7:51AM
​
Click here: PerthNow, Stay in, Stand Up to read the full article.
7 News Exclusive
Watch our Exclusive on 7 News Perth
​
EXCLUSIVE: A Perth mum who fought and won a battle with a dangerous and rare form of cancer, says she owes her life to a doctor who refused to give up hope.
​
​
Pancreatic and Stomach Cancer Awareness Month
November is Pancreatic Cancer and Stomach Cancer Awareness Month
These cancers are often called the silent killers. They are difficult to detect and survival rates are tragically low.
More than 7,000 Australians will be diagnosed with one of these diseases this year.
​
You can change the odds
Any donation, no matter the size, will help us to conduct clinical trials that lead to better health outcomes for people diagnosed with pancreatic and stomach cancer.
​
​
Listen to 6PR's 'Mornings with Liam Bartlett' talking with WARPNINE Chair, Dr Andrew Dean and CEO, Meg Croucher.
Click HERE to listen.